112 results about "Weight management" patented technology

The invention discloses a composition for regulating body weight through satiety-sugar control double channels. The composition is prepared from the following components in parts by weight: 5-25 parts of cinnamon extract, 1-20 parts of ganoderma lucidum EGCG composite powder, 10-40 parts of L-arabinose, 5-40 parts of composite fruit and vegetable fiber powder, 5-25 parts of fructus cannabis protein peptide, 1-20 parts of apple polyphenol, 1-20 parts of white kidney bean dietary fiber powder and 1-20 parts of agaricus bisporus powder. The composition is characterized in that digestion and absorption of carbohydrate are inhibited, the swelling ratio larger than or equal to 35 times is achieved through a composite fiber system, gastric emptying is remarkably prolonged, satiety hormones such as GLP-1 are adjusted, and the composition can be used as a non-alternative weight management product and is good in safety.

The present application relates to heterobicyclic compounds having glucagon-like peptide receptor (GLP-1R) agonist activity, processes for their preparation, pharmaceutical compositions comprising them and their use as GLP-1R agonists or for the treatment or prophylaxis of GLP-1R associated diseases or disorders. In particular, the compounds of the present application are useful for body weight management, for lowering blood sugar and / or for the treatment or prevention of diabetes, diabetic complications, obesity, overweight, dyslipidemia, fatty liver diseases (e.g., non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)), metabolic diseases, cardiovascular diseases, nervous system disorders, mental disorders, kidney diseases, etc. , gastrointestinal diseases, autoimmune diseases, inflammatory diseases, lung diseases, hypothalamic-pituitary-gonad axis related diseases or disorders, cancers and the like.

The present application relates to use of Ligilactobacillus salivarius in preparing a drug for preventing and / or treating diseases associated with overweight and / or obesity . The strain can inhibit the weight growth of a high-fat diet-induced obesity model mouse, reduce the blood lipid level of the high-fat diet-induced obesity model mouse, improve the liver injury index of the high-fat diet-induced obesity model mouse, reduce the area of white adipose cells of the high-fat diet-induced obesity model mouse, improve the colon GLP-1 level of the high-fat diet-induced obesity model mouse, improve the intestinal flora imbalance of the high-fat diet-induced obesity model mouse, and improve the liver glycolipid metabolism of the high-fat diet-induced obesity model mouse; and reduce the waist circumference, hip circumference, body fat mass, BMI, and weight of overweight and overweight and / or obesity volunteers, and maintain the muscle content, promoting overweight and overweight and / or obesity people to carry out safe, effective, and sustainable weight management.

The present invention relates to the technical field of food and drugs, and in particular to a hydrogel material composition, and a weight management composition, a preparation method therefor and a use thereof. The hydrogel material composition comprises konjac powder, galactomannan, and resistant dextrin. The weight management composition comprises the following components in parts by mass: 40-60 parts of a hydrogel material composition, 10-40 parts of a disintegrating agent, 0-15 parts of inorganic salt, and 10-35 parts of a filler. In the present invention, the composition prepared from specific components and by specific proportions can have good preparation performance, disintegration performance, and gelling performance; the product quality stability is high; the composition is suitable for large-scale application development; and the composition can occupy the space in the stomach after being eaten, so that satiety is promoted, and the appetite is reduced, thereby achieving the purposes of realizing weight management, blood sugar control and the like.

The invention pertains to an inhalable dry powder formulation comprising a therapeutically effective amount of Glucagon-like peptide-1 (GLP-1) receptor agonist. Further, use of the inhalable dry powder formulation treatment of chronic weight management for people who are overweight or obese, with or without a weight-related comorbid condition. Further, a process for forming particles comprising a Glucagon- like peptide-1 (GLP-1) receptor agonist suitable for airborne inhalation.

1. Name of the product of this design: Dining Tray (Weight Management). 2. Purpose of this design product: used for holding food. 3. The key design points of this product are the combination of shape, pattern and color. 4. The picture or photo that best illustrates the design points: three-dimensional picture. 5. The design for which protection is sought includes color.

The invention specifically relates to a smoking cessation person weight management auxiliary method and system, and the method comprises the steps: obtaining a current multi-source weight data set of a user in response to a user data feedback signal of a smoking cessation person, the current multi-source weight data set at least comprises genotype data features of the user, current weight data features and various types of life behavior data features; the current multi-source weight data set of the user is substituted into the intelligent weight management model, a weight management scheme matched with the user is selectively updated or generated, and the weight management scheme at least comprises a diet suggestion parameter set, an exercise suggestion parameter set and a current target combination parameter set; and obtaining a feedback instruction of the user for the body weight management scheme matched with the user, and selectively adjusting the intelligent body weight management model based on the feedback instruction. When the change of any data of the smoking cessation person is monitored, the body weight management scheme is automatically adjusted, and it is ensured that the user is matched with the body weight management scheme.

This invention discloses a weight management system, method, device, and storage medium for overweight and obese individuals based on standardized operating procedures, belonging to the field of health management technology. It includes an information collection and standardized input module; a health risk analysis and assessment module; a personalized intervention plan configuration module; a dynamic intervention execution and tracking management module; and an effect evaluation and optimization feedback module. The system of this invention achieves standardized collection of multi-dimensional basic data of users, health risk assessment and classification, standardized health risk assessment and classification, and effect evaluation and optimization feedback by constructing a collaborative operating system of the information collection and standardized input module, the health risk analysis and assessment module, the personalized intervention plan configuration module, the dynamic intervention execution and tracking management module, and the effect evaluation and optimization feedback module. Simultaneously, it identifies abnormal behaviors and generates early warning information through early warning rules, and uses the effect evaluation and optimization feedback module to comprehensively evaluate and dynamically optimize the intervention plan execution process.

This invention discloses a compound peptide nutrient with fat-reducing effects, belonging to the field of health food technology. Specifically, it relates to a VQPIPY peptide or a product containing VQPIPY peptide in the preparation of lipid-lowering drugs or health products, or in the preparation of drugs for treating and / or alleviating alcoholic liver damage. This invention also provides a meal replacement powder containing VQPIPY peptide, shown as a compound of whey powder, milk powder, oats, spinach powder, allulose, and camel milk peptide in a specific ratio. Through the synergistic effect of its components, this product achieves multiple effects such as providing satiety, inhibiting blood sugar, and lowering blood lipids. It is characterized by balanced nutrition, safety, effectiveness, and good taste, and can be used for weight management and daily health maintenance.

This invention discloses the application of *Lactobacillus plantarum* TWK10 in the preparation of health foods or drugs that enhance exercise motivation. *Lactobacillus plantarum* TWK10, with its Latin name *Lactobacillus plantarum*, was deposited on June 27, 2022, at the China General Microbiological Culture Collection Center (CGMCC), located at No. 3, Courtyard 1, Beichen West Road, Chaoyang District, Beijing, with accession number CGMCC NO. 25190. This invention fills a technological gap in the field of probiotics for sports psychology intervention, providing a new strategy for "physiological-psychological" dual-effect intervention in sports nutrition, and can be further applied to weight management.

The invention provides a coffee and soybean milk composition for body weight management and a preparation method thereof. The coffee and soybean milk composition comprises the following components in parts by mass: 10-20 parts of a coffee component, 20-60 parts of a soybean protein component, 5-10 parts of a mitochondrial activator and 5-15 parts of dietary fibers. According to the coffee and soybean milk composition provided by the invention, the coffee component, the soybean protein component, the mitochondrial activator and the dietary fiber are scientifically and specifically proportioned, so that key functional components, namely caffeine and chlorogenic acid in coffee, generate a synergistic biological effect with the soybean protein; and a coordinated regulation system of a targeted lipid metabolism full chain is systematically constructed. According to the preparation method, the coffee-dietary fiber microcapsule powder is obtained through a microencapsulation process, the structure can effectively protect heat-sensitive components such as chlorogenic acid and part of aroma substances in coffee from being damaged in the processing and storage process, and the synergistic effect performance of beneficial components in the coffee and soybean milk composition in the human body is guaranteed.

The present disclosure relates to the field of medicine. More particularly, the disclosure is in the field of treatment of diabetes, obesity and / or chronic weight management, dyslipidemia and / or NASH. The disclosure relates to compounds that agonize the amylin receptor and can lower food intake, body weight, glucose and / or triglycerides, so can be used to treat diabetes, obesity, and / or dyslipidemia. The present disclosure also includes pharmaceutical compositions containing such compounds and therapeutic uses of such compounds and compositions.

The invention provides a composition for body weight management as well as a preparation method and application thereof. The composition for body weight management is prepared from the following raw materials: raspberry, sophora flower bud, cinnamon, poria cocos, oat and grapefruit. According to the present invention, according to the traditional Chinese medicine diet therapy concept, the raspberry, the sophora flower bud, the cinnamon, the poria cocos, the oat, the grapefruit and other medicinal and edible components are selected, and the components beneficial to weight management are matched based on the modern scientific research, such that the compatibility principle of monarch, minister, assistant and guide is provided, and the clear targeting effect mechanism is provided; six components in the composition have a synergistic effect, and the obvious effects of weight management, weight losing and fat reducing can be achieved.

The present invention discloses a guarana extract – EGCG synergistic fat-burning composition, belonging to the technical field of functional foods and weight management. The composition comprises guarana extract, epigallocatechin gallate, and konjac glucomannan. By controlling the component ratio and key parameters, a dynamic gel network formed by konjac glucomannan provides in-situ protection of active ingredients and enables programmed release in the gastrointestinal tract, while constructing a multi-level appetite-suppression system with temporal continuity.The invention overcomes problems in the prior art, including poor stability, low bioavailability, and fragmented appetite regulation, and achieves synergistic effects in fat burning and intake control. It is suitable for preparing oral solid formulations, with high safety, good stability, and suitability for large-scale industrial production and commercialization.

The invention discloses a composition capable of being used for body weight management and a preparation method and application thereof, and belongs to the technical field of foods.The composition is prepared from, by weight, 15-50 parts of compound protein powder solid beverage, 2-15 parts of quinoa flour and 1-8 parts of compound fruit and vegetable powder. The quinoa flour is prepared through high-pressure homogenization, composite enzymolysis, ethanol extraction and supercritical extraction. Experiments prove that the chenopodium quinoa flour prepared by the method has more advantages in the aspect of controlling weight management, and the goals of enhancing satiety and reducing total calorie intake are achieved while nutrition balance is guaranteed through the combined action of the chenopodium quinoa flour, the compound protein powder solid beverage and the compound fruit and vegetable powder.

The invention discloses application of a nutritional composition containing alpha-hydroxyisocaproic acid in weight management and blood fat improvement, and belongs to the fields of biological medicine manufacturing, biological medicine application and functional food development. The nutritional composition comprises alpha-hydroxyisocaproic acid and at least one second functional nutritional component, and the second functional nutritional component is preferably selected from one or more of the following components: 1) one or more of tea polyphenol and capsaicin; 2) one or more of beta-glucan, inulin and resistant dextrin; 3) one or more of medium chain triglyceride and sn-1, 3 diglyceride; under the condition of the same intake cycle and dosage, the nutritional composition can significantly improve the weight management effect and reduce related indexes of blood fat through a multi-way synergistic effect, and is combined with GLP-1 drugs or sequentially applied to weight management so as to reduce the risk of weight rise after drug withdrawal.

The present invention relates to pharmaceutical combinations comprising bupropion and trazodone and methods of using the same for affecting weight loss in subjects who may be obese, overweight or desire to lose undesirable or unwanted weight. The present invention also relates to pharmaceutical combinations comprising bupropion and trazodone and methods of using the same for inducing weight loss, effectuating weight management, improving a sexual disorder, and / or improving low or poor or a lack of a subjective state of well-being, self-esteem, and / or self-confidence in subjects who may be obese, overweight or desire to lose undesirable or unwanted weight or who want to maintain weight. The present invention also relates to pharmaceutical combinations comprising bupropion and trazodone and methods of using the same for weight loss and / or weight maintenance management.

An integrated weight management system comprising a biocompatible intraoral device and personalized software is disclosed. The device, configured for insertion into the user's mouth, creates a separation between the tongue and teeth causing the stomatognathic system, limiting hunger cues associated with food anticipation. Sensors coupled to the device detect its removal and insertion, enabling the system to track adherence to meal plans and weight loss progress. The software utilizes machine learning algorithms to generate personalized meal plans, food intake timing, nutrition education, and exercise routines based on user preferences, dietary restrictions, and weight loss goals. The system analyzes user data to provide progress reports, adjust meal plans, and send alerts to promote accountability and compliance. This comprehensive approach addresses both physiological and psychological aspects of weight management, offering a novel and effective solution for achieving and maintaining a healthy weight.

A polypeptide that is active against each of a GIP, a GLP-1, and a glucagon receptor is provided. The polypeptides have structural features that result in each of the receptors having activity and extended action time. Also provided are methods for treating diseases and / or conditions such as obesity, long term weight management, type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), dyslipidemia, metabolic syndrome, chronic kidney disease (CKD), osteoarthritis (OA), obesity-associated sleep apnea (OSA), and polycystic ovarian syndrome (PCOS).

The invention discloses a low-GI gluten-free fat-reducing bean dreg and scallop bread formula and a preparation method thereof. Relates to the technical field of food, and is prepared from the following raw materials in parts: 150 parts of dry bean dreg powder, 20 parts of ocean car shell powder, 20 parts of coconut flour, 60 parts of momordica grosvenori erythritol, 10 parts of baking powder, 5 parts of baking soda, 300 parts of drinking water, 10 parts of lemon juice, 200 parts of egg liquid, 280 parts of mozzarella cheese, and 10 parts of crushed grains and nuts. The low-GI gluten-free fat-reduced bean dreg and scallop bread has the effects of low glycemic index, low GI, fat reduction and the like, is close to scallop bread made of wheat flour in taste, is soft and delicious, is suitable for serving as a daily staple food for related sugar-controlled people with diabetes, weight management and the like, is beneficial to improving the blood sugar level and improving the overall health condition of citizens, does not contain gluten, and is suitable for being eaten by people with diabetes, weight management and the like. The flour is especially suitable for gluten allergy people to eat.

The application discloses a composition capable of being used for weight management and a preparation method and application thereof, and belongs to the field of food technology.The composition is composed of the following raw materials in parts by weight: 15-50 parts of composite protein powder solid beverage, 2-15 parts of quinoa powder and 1-8 parts of composite fruit and vegetable powder; the quinoa powder is prepared through high-pressure homogenization, composite enzymolysis, ethanol extraction and supercritical extraction. Experiments prove that the prepared quinoa powder has more advantages in weight control management, and meanwhile, the three of the quinoa powder, the composite protein powder solid beverage and the composite fruit and vegetable powder are used to jointly ensure balanced nutrition, enhance satiety and reduce total calorie intake.

The invention relates to the fields of biotechnology, traditional Chinese medicines and nutritional health-care products, in particular to a bifidobacterium breve-containing medicinal and edible composite composition and application thereof in preparation of products for preventing or treating anxiety and depression, improving sleep disorders and assisting in weight management. The composite composition is prepared from bifidobacterium breve and a medicinal and edible composition, and the ratio of the bifidobacterium breve to the medicinal and edible composition is 1 * 10 < 10 > CFU of the bifidobacterium breve and 60 g of the medicinal and edible composition. The composition disclosed by the invention has a remarkable synergistic effect, can effectively prevent or relieve anxiety and depression symptoms, can improve sleep quality, and can assist in reducing body weight and body fat. The action mechanism relates to double targets of'intestine-brain-metabolic axis', and the double targets supplement each other to synergistically promote nerve-immunity-endocrine and metabolic balance. The composition disclosed by the invention can be used for preparing medicines, functional foods or health-care products, and provides a safe and effective brand-new choice for intervention of multiple health problems (emotion, sleep and metabolic disorders).

Provided herein are compositions, formulations, and methods of treatment for weight loss and satiety improvement for a subject in need thereof, including a human subject in need thereof. The compositions may be used to improve satiety, insulin sensitivity and the microbiome in a subject in need thereof. The composition may further used for weight management and / or in mammals, including humans.

The invention discloses a postbiotic preparation with weight and fat reducing effects as well as a preparation method and application of the postbiotic preparation, and belongs to the technical field of microbial fermentation preparations and food. Comprising inactivated probiotics, a compound fermentation substrate and metabolites generated by fermenting the compound fermentation substrate by the probiotics, the probiotics are casei paracasei; the composite fermentation substrate comprises apples, potatoes, corn stigma and oranges. According to the invention, the lactobacillus paracasei is adopted as the probiotics to ferment the composite fermentation substrate containing a plurality of natural dietary components, so that the postbiotic preparation with dual effects of reducing weight and fat is successfully developed. The metagen preparation can help people with weight management requirements to reduce fat and weight, and has good practical application value.

The present disclosure provides a GLP-1 receptor agonist semaglutide for use in medical therapy including weight management.

Provided is use of an MDM2 inhibitor in weight management by inducing weight loss in a subject, as well as the MDM2 inhibitor in the treatment and / or prevention of obesity, dyslipidemia, a non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and / or type 2 diabetes. The present invention further relates to a method for using the MDM2 inhibitor in the use.

This invention discloses an instant gelling powder of sodium alginate / calcium β-hydroxy-β-methylbutyrate with dual functions of fat reduction and muscle gain, and its application, belonging to the field of functional food or pharmaceutical preparation technology. The powder of this invention is prepared by dry mixing sodium alginate and CaHMB at a weight ratio of 5~10:1~5, preferably 7:3, wherein the guluronic acid content of sodium alginate is ≥50%. In use, 1g of powder is added to 20~40mL of water at 60~100°C, and stirred to form a hydrogel. After oral administration, the powder rapidly forms a gel in the stomach, producing a feeling of fullness, and simultaneously achieves fat reduction, muscle gain, and metabolic regulation functions by regulating myostatin expression. This invention overcomes the limitation of existing weight management products with only one function, innovatively integrating the three major effects of instant satiety, fat reduction, and muscle gain. The preparation process is simple and environmentally friendly, requiring no added chemical excipients, and has significant technological advancement and market application value.

The present invention provides a method of increasing glycemic control in a patient in need thereof by administering tizatide, or a pharmaceutically acceptable salt thereof. The present invention provides a method of improving body weight management in a patient in need thereof by administering tizatide, or a pharmaceutically acceptable salt thereof. Also provided is a method of treating a condition selected from the group consisting of atherosclerosis, chronic kidney disease, NAFLD and NASH. Also provided is a method of preventing or causing alleviation of diabetes mellitus, comprising administering tizatide or a pharmaceutically acceptable salt thereof. Also provided is a dosing regimen for increasing glycemic control, improving weight management, and / or treating dyslipidemia.

A method for increasing functional and organoleptic properties of compositions having elements of biological origin more particularly herbal formulations is disclosed. Nutraceutical formulations for diabetes management and fortification of pulses and grains to lower oil absorption during frying are also disclosed. These foods are effective for weight management.

The embodiment of the invention discloses a weight management large model customization service method and system for special crowds. The method comprises the steps of collecting multi-source heterogeneous data of a target user, wherein the multi-source heterogeneous data at least comprises data collected through wearable equipment; processing the multi-source heterogeneous data by using a first model to obtain a first identification result when identifying that the target user belongs to the special crowd and identifying a target category of the special crowd to which the target user belongs; a second model corresponding to the target category is combined with the first information of the target user and the first recognition result to obtain a second recognition result; the first information is information associated with the target category; the second identification result comprises a second identification item; the first identification item is a non-key item of the target category; formulating a health maintenance report according to the second identification result; the health maintenance report at least comprises a weight management item and a health index monitoring item associated with the target category.